Armando Arenas

Armando Arenas Intellectual Property and Litigation Attorney Olivares Law Firm Mexico City
Partner
Organization Profile
Connect
+52 (55) 5322 3000 Ext. 3906
Professional Biography

Armando Arenas joined OLIVARES in 2000 and became a partner in January 2017. He has experience working on a range of IP matters, including consulting and litigation on trademark, patent, unfair competition, trade dress protection, and misleading advertising cases before the Mexican Institute of Industrial Property (IMPI), Federal Court of Tax and Administrative Affairs (FCTA), Federal Circuit Courts (FCC) and the Supreme Court of Justice (SCJ) Regulatory Affairs and Public Acquisitions. Mr. Arenas is especially adept in patent litigation and protection under Mexico’s patent linkage system and regularly handles cases before the Federal Commission for Protection against Sanitary Risks (COFEPRIS). He has extensive experience with regulatory matters under Mexico’s health laws and provides strategic advice in complex patent litigation cases and dispute resolutions. His clients and representative cases span all sectors of the health industry, including pharma, biotech, medtech, diagnostics, animal health, vaccines, and health services.

  • Latest Legal and Business Bylines From Armando Arenas

OLIVARES has been named a 2022 Go-To Thought Leader in the field of Biotech, Food, and Drug Law by the National Law Review. In 2022, vapes and electronic cigarettes saw substantial regulation and oversight around the world. OLIVARES attorneys Alejandro Luna Fandiño, Armando Arenas, and Gustavo A. Alcocer authored a noteworthy article detailing the state of these regulations throughout Mexico, including the sale of vaping and e-cigarette devices, and the constitutionality of the government’s various regulatory decrees. The article’s wide readership demonstrates the author’s depth of knowledge on the topic and the widespread interest in the firm’s ongoing news coverage.

 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins